Medtronic caps fiscal year with revenue surge and 49th dividend increase
Compartilhar
Medtronic (NYSE:MDT) reported a 9.9% increase in fourth-quarter revenue to $9.8 billion, closing out its fiscal year 2026 with broad-based operational momentum across its core therapeutic portfolios.
